Johnson & Johnson
JNJ- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000200406
In the last 90 days, Johnson & Johnson insiders filed 0 open-market purchases and 6 sales; 4,701 institutions reported holding it in 13F filings for Q2 2026, worth $456.9B in total; 5 superinvestors hold it, including Markel Group and Fairfax Financial.
Q3 2022 vs. Q2 2022
How the institutions holding Johnson & Johnson changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 3,680 | 48 | 3,629 | −3 |
| Shares | 1.82B | 1.53M | 1.81B | −6.77M (−0.4%) |
| Value | $322.7B | $261.4M | $295.6B | −$26.8B (−8.3%) |
48 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (113)
Institutions that held Johnson & Johnson at the end of Q3 2022 but not at the end of Q2 2022.
Showing the largest 100 of 113 by value.
Sold out (116)
Institutions that held Johnson & Johnson at the end of Q2 2022 and filed for Q3 2022 without it.
Showing the largest 100 of 116 by value.
Not filed for Q3 2022 yet (48)
Institutions that held Johnson & Johnson at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.